https://www.selleckchem.com/pr....oducts/anacetrapib-m
The results showed that bounding the JSN progression of both knees can result to more robust prediction models with a higher accuracy (83.3%) and with fewer risk factors (29) compared to the right knee (77.7%, 88 risk factors) and the left knee (78.3%, 164 risk factors), separately. The risk of cardiovascular (CV) and fatal events remains extremely high in patients with maintenance hemodialysis (MHD), and the growth differentiation factor 15 (GDF15) has emerged as a valid risk stratification biomarker. We aimed to develop a
Like
Comment
Share
